Zhiyun Yu
Jilin Normal University(CN)First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Urinary Bladder and Prostate Research, PI3K/AKT/mTOR signaling in cancer, Prostate Cancer Diagnosis and Treatment, Glioma Diagnosis and Treatment, Pelvic floor disorders treatments
Most-Cited Works
- → NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells(2015)115 cited
- → Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cellsin vitroandin vivo(2015)101 cited
- → What role do surfaces play in GB models? A new‐generation of surface‐generalized born model based on a novel gaussian surface for biomolecules(2005)94 cited
- → Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells(2016)91 cited
- → First-Shell Solvation of Ion Pairs: Correction of Systematic Errors in Implicit Solvent Models(2004)78 cited
- → AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin(2016)69 cited
- → Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression(2018)65 cited
- → Glioma exosomal microRNA-148a-3p promotes tumor angiogenesis through activating the EGFR/MAPK signaling pathway via inhibiting ERRFI1(2020)58 cited
- → Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells(2016)54 cited
- → Dual blocking of PI3K and mTOR signaling by NVP-BEZ235 inhibits proliferation in cervical carcinoma cells and enhances therapeutic response(2016)39 cited